Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-31,726
Closed -$889K 1545
2016
Q4
$889K Buy
31,726
+4,095
+15% +$115K 0.04% 539
2016
Q3
$758K Buy
27,631
+40
+0.1% +$1.1K 0.04% 506
2016
Q2
$738K Buy
27,591
+598
+2% +$16K 0.04% 529
2016
Q1
$603K Buy
26,993
+2,404
+10% +$53.7K 0.06% 430
2015
Q4
$680K Sell
24,589
-1,688
-6% -$46.7K 0.08% 285
2015
Q3
$678K Buy
26,277
+256
+1% +$6.61K 0.07% 338
2015
Q2
$645K Buy
+26,021
New +$645K 0.06% 398

Other funds holding QGENF

Amalgamated Bank's QGENF Position: Q1 2017 in Review

Amalgamated Bank sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 31,726 shares — an estimated $889K sold.

Amalgamated Bank first reported a position in QGENF in Q2 2015 and held it in 7 quarters. The position peaked at $889K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Amalgamated Bank reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Amalgamated Bank sold 31,726 QIAGEN NV shares in Q1 2017, an estimated $889K.
  • Amalgamated Bank first reported a position in QIAGEN NV in Q2 2015 and held it in 7 quarters.
  • Amalgamated Bank's QIAGEN NV position peaked at $889K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Amalgamated Bank's 13F filing for Q1 2017, filed 12 May 2017.